Endometriosis: The Evidence-Based Supplement Protocol

← Back to articles

Endometriosis is driven by ectopic endometrial-like tissue, chronic inflammation, and (in many cases) estrogen-dependent growth. Hormonal therapy (combined oral contraceptives, progestins including the levonorgestrel IUD, GnRH analogues) and surgical excision remain the established interventions; the 2022 ESHRE guideline notes that even among these, evidence quality is often limited and no single approach is clearly best. For supplements, the honest summary is that the evidence is genuinely thin. The trials are small, mostly conducted in single centers, frequently at moderate-to-high risk of bias, and — in the best-quality study to date — supplements did not separate from a large placebo response. Where supplements help, the most consistent benefit is on dysmenorrhea (period pain), not chronic pelvic pain or painful intercourse. This protocol grades the options realistically and frames them as possible adjuncts to medical care, never replacements.

Melatonin — The Single Best-Evidenced Supplement Here

Evidence grade: limited but the most convincing. In a phase II double-blind RCT of 40 women (Schwertner 2013), melatonin 10 mg/day reduced daily pain scores by about 40% and dysmenorrhea by about 38% versus placebo, improved sleep quality, and reduced the use of rescue analgesics by roughly 80% over 8 weeks. Two later meta-analyses singled out melatonin (alongside vitamin D) as one of the few agents showing a statistically significant effect on dysmenorrhea. The trial is small and unreplicated at scale, but the signal is the strongest in this space. Typical dose studied: 10 mg at night. Caution: causes drowsiness; take at bedtime and avoid driving afterward.

Vitamin D — Mixed, Reasonable to Correct a Deficiency

Evidence grade: limited and inconsistent. Vitamin D deficiency is more common in endometriosis cohorts than in controls. One RCT in 60 patients (Mehdizadehkashi 2021) found vitamin D reduced pelvic pain and inflammatory markers (hs-CRP). But the highest-quality trial — the double-blind SAGE study in adolescents and young women (Nodler 2020) — found that while the vitamin D arm improved, the improvement was nearly identical to placebo and not statistically different from it. Meta-analyses are split, with vitamin D's pain effect reaching significance in some pooled analyses and not others. Correcting a documented deficiency is sensible for general health; expecting vitamin D to control endometriosis pain on its own is not well supported.

Omega-3 (EPA/DHA) — Anti-Inflammatory, Weak Pain Data

Evidence grade: limited. Omega-3 fatty acids (EPA and DHA) reduce inflammatory signaling and have low-quality supportive evidence in primary dysmenorrhea, which overlaps with endometriosis pain. However, in the SAGE trial the fish-oil arm produced only about half the pain reduction seen in the other arms and did not beat placebo, and the Cochrane review of dietary supplements for dysmenorrhea rated all such evidence as low or very low quality. Omega-3 is safe and has independent cardiometabolic value, so it is a defensible adjunct, but it should not be sold as a proven pain treatment. Typical dose: 1–2 g/day combined EPA+DHA.

N-Acetylcysteine (NAC) — Intriguing, But Only Observational Data

Evidence grade: insufficient. The widely cited NAC study (Porpora 2013) is frequently described as a trial, but it was an observational cohort: Italian women with ovarian endometriomas chose NAC or no treatment, and the NAC group showed slightly reduced cyst size and fewer scheduled surgeries. Because treatment was not randomized, the result is hypothesis-generating only. NAC is a glutathione precursor and biologically plausible, but it has not been validated for endometriosis in a properly controlled trial. Caution: do not combine NAC with nitroglycerin (additive hypotension/headache).

Curcumin and Antioxidant Vitamins — Conflicting Results

Evidence grade: limited and conflicting. Curcumin is anti-inflammatory in the lab, but the clinical trials disagree: a 2023 triple-blind RCT of curcumin 500 mg twice daily as monotherapy found no effect on endometriosis pain or quality of life, whereas a 2025 trial of nanocurcumin added to dienogest did improve pain versus dienogest alone. The most reasonable reading is that curcumin may have value as an add-on to hormonal therapy but is not a standalone treatment. For antioxidant vitamins, meta-analyses suggest vitamin E (with or without vitamin C) may modestly reduce pelvic pain, but heterogeneity is high and low-bias studies tend to be null.

What Doesn't Work / Overhyped

Resveratrol is often promoted for endometriosis, but there is no convincing randomized evidence that it relieves pain, and its oral bioavailability is poor — treat it as unproven. High-dose soy isoflavones are best avoided in an estrogen-dependent condition out of caution (ordinary dietary soy is fine), and DHEA is an androgen precursor that can aromatize to estrogen. "Estrogen detox" and "hormone-balancing" formulas are pharmacologically incoherent. No supplement has been shown to shrink lesions or substitute for hormonal or surgical management.

How to Run the Protocol

Medical and (where indicated) surgical care directed by a gynecologist remains primary; supplements are at most adjuncts and the evidence behind them is weak. If you and your clinician want to trial a supplement, melatonin at bedtime has the most supportive data for pain and sleep, and is a reasonable first choice. Correct a documented vitamin D deficiency. Omega-3 and an add-on curcumin alongside hormonal therapy are low-risk options worth a defined trial. Track pain on a simple 0–10 scale and quality of life over about 12 weeks, and stop anything that is not clearly helping. Be skeptical of any product or protocol promising to cure endometriosis.